Cargando…
The Safety and Exploration of the Pharmacokinetics of Intrapleural Liposomal Curcumin
BACKGROUND: Malignant pleural effusion (MPE) is the accumulation of fluid in the pleural cavity as a result of malignancies affecting the lung, pleura and mediastinal lymph nodes. Curcumin, a compound found in turmeric, has anti-cancer properties that could not only treat MPE accumulation but also r...
Autores principales: | Hocking, Ashleigh, Tommasi, Sara, Sordillo, Peter, Klebe, Sonja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023862/ https://www.ncbi.nlm.nih.gov/pubmed/32103948 http://dx.doi.org/10.2147/IJN.S237536 |
Ejemplares similares
-
Study protocol of a phase 1 clinical trial establishing the safety of intrapleural administration of liposomal curcumin: curcumin as a palliative treatment for malignant pleural effusion (IPAL-MPE)
por: Hocking, Ashleigh Jean, et al.
Publicado: (2021) -
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc(™)) in patients with locally advanced or metastatic cancer
por: Greil, Richard, et al.
Publicado: (2018) -
The Significance of Short Latency in Mesothelioma for Attribution of Causation: Report of a Case with Predisposing Germline Mutations and Review of the Literature
por: Klebe, Sonja, et al.
Publicado: (2021) -
Pharmacokinetic profile of paclitaxel in the plasma, lung, and diaphragm following intravenous or intrapleural administration in rats
por: Li, Jie, et al.
Publicado: (2015) -
Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion
por: Moon, Youngkyu, et al.
Publicado: (2015)